Ming-Gao Zhao Selected Research

Anti-Anxiety Agents (Anxiolytics)

1/2022	Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice.
7/2021	Scutellarin ameliorates the stress-induced anxiety-like behaviors in mice by regulating neurotransmitters.
1/2020	Anxiolytic effects of polydatin through the blockade of neuroinflammation in a chronic pain mouse model.
1/2019	Anxiolytic effects of Formononetin in an inflammatory pain mouse model.
1/2019	Effects of CPEB1 in the anterior cingulate cortex on visceral pain in mice.
1/2018	Anxiolytic effect of CPEB1 knockdown on the amygdala of a mouse model of inflammatory pain.
12/2016	Gastrodin relieved complete Freund's adjuvant-induced spontaneous pain by inhibiting inflammatory response.
7/2016	Anxiolytic effects of sesamin in mice with chronic inflammatory pain.
3/2015	Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Gao Zhao Research Topics

Disease

27	Pain (Aches) 01/2022 - 01/2005
11	Inflammation (Inflammations) 10/2021 - 11/2005
8	Chronic Pain 01/2021 - 08/2006
5	Neuroinflammatory Diseases 01/2022 - 01/2019
4	Memory Disorders (Memory Loss) 12/2017 - 10/2008
3	Neoplasms (Cancer) 12/2022 - 07/2015
3	Fragile X Syndrome (Martin Bell Syndrome) 12/2017 - 05/2012
3	Brain Ischemia (Cerebral Ischemia) 10/2016 - 10/2015
2	Cognitive Dysfunction 10/2021 - 01/2018
2	Anxiety Disorders (Anxiety Disorder) 07/2021 - 06/2013
2	Visceral Pain 01/2020 - 01/2019
2	Hypoxia (Hypoxemia) 12/2017 - 03/2016
2	Intellectual Disability (Idiocy) 12/2017 - 10/2009
2	Central Nervous System Diseases (CNS Diseases) 01/2017 - 01/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2017 - 10/2016
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2016 - 07/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2016 - 12/2013
2	Hypertrophy 01/2016 - 07/2010
2	Alzheimer Disease (Alzheimer's Disease) 11/2015 - 04/2013
2	Substance-Related Disorders (Drug Abuse) 06/2013 - 04/2006
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Bronchitis 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 10/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2020
1	Headache (Headaches) 01/2020
1	Rhinitis 01/2020
1	Hyperalgesia 06/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Postpartum Depression (Post-Natal Depression) 01/2018
1	Atherosclerosis 01/2018
1	Type 2 Diabetes Mellitus (MODY) 12/2017
1	Necrosis 12/2017
1	Huntington Disease (Huntington's Disease) 02/2017
1	Sleep Deprivation 01/2017
1	Rheumatic Fever (Acute Articular Rheumatism) 01/2017

Drug/Important Bio-Agent (IBA)

12	Freund's AdjuvantIBA 01/2022 - 08/2006
9	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2007
9	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022 - 03/2015
9	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 11/2005
8	N-Methylaspartate (NMDA)IBA 01/2022 - 11/2005
7	Analgesics (Analgesic Drugs)IBA 01/2022 - 06/2008
6	LigandsIBA 01/2018 - 03/2015
4	AMPA Receptors (AMPA Receptor)IBA 01/2022 - 09/2005
3	Pharmaceutical PreparationsIBA 12/2022 - 11/2015
3	Liver X ReceptorsIBA 10/2021 - 01/2018
3	Antidepressive Agents (Antidepressants)IBA 10/2020 - 01/2018
3	PlasticsIBA 01/2020 - 08/2006
3	gentiopicrosideIBA 10/2018 - 06/2008
3	AntioxidantsIBA 01/2018 - 12/2016
3	Fragile X Mental Retardation ProteinIBA 12/2017 - 10/2009
3	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2016 - 01/2006
2	Biological ProductsIBA 10/2022 - 11/2015
2	Small Interfering RNA (siRNA)IBA 10/2021 - 06/2019
2	LipopolysaccharidesIBA 10/2021 - 01/2019
2	CytokinesIBA 10/2021 - 01/2021
2	praeruptorin CIBA 01/2021 - 02/2017
2	ZymosanIBA 01/2020 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 03/2007
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2017 - 12/2016
2	Estrogen ReceptorsIBA 01/2017 - 04/2015
2	Neuroprotective AgentsIBA 10/2016 - 10/2015
2	Peptides (Polypeptides)IBA 06/2013 - 12/2006
2	CalciumIBA 07/2010 - 01/2006
2	Serotonin (5 Hydroxytryptamine)IBA 07/2010 - 06/2002
2	Calcium-Calmodulin-Dependent Protein Kinase Type 4IBA 10/2008 - 04/2006
2	Transcription Factors (Transcription Factor)IBA 10/2008 - 04/2006
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2008 - 04/2006
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 08/2006 - 01/2006
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022
1	tanshinoneIBA 10/2022
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 10/2021
1	Protein Isoforms (Isoforms)IBA 10/2021
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	HMGB1 Protein (HMG1)IBA 10/2021
1	GW 3965IBA 10/2021
1	Toll-Like Receptor 4IBA 10/2021
1	Kainic Acid (Kainate)IBA 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	Minocycline (Cyclops)FDA LinkGeneric 10/2020
1	Cyclic AMP (AMP, Cyclic)IBA 01/2020
1	EnzymesIBA 01/2020
1	polydatinIBA 01/2020
1	ScopoletinIBA 01/2020
1	CholesterolIBA 06/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 06/2019
1	formononetinIBA 01/2019
1	Tuberculin (PPD)IBA 01/2018
1	2',3',4',5'- tetrahydroxystilbene- 2- O- beta- D- glucosideIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	ThiazolidinedionesIBA 12/2017
1	Aldehyde Reductase (Aldose Reductase)IBA 12/2017
1	NF-kappa B (NF-kB)IBA 12/2017
1	ProgranulinsIBA 12/2017
1	3-nitropropionic acidIBA 02/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2017
1	angelicinIBA 01/2017

Therapy/Procedure

4	Therapeutics 12/2022 - 06/2013
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 01/2017